Alzamend (ALZN) Company Cash Funds

Official company branding of alzamend.com (ALZN)

Alzamend Neuro, Inc. (ALZN) utilizes AI and automated laboratories to design Alzheimer's medications. The cash position reflects reserve dynamics, where the 0.01 indicator expresses the state of the metric. The issuer is developing immunotherapy by relying on investments for testing. However, the biotech's success is tied to early research results and the necessity of continuously raising external capital.

Company Cash Reserve: Alzamend Neuro (ALZN) for 07/04/2022 - 11/21/2026

Analytical breakdowns and data insights for company alzamend.com (ALZN)

- current price and projected stock value:
Summary company analytics:Alzamend Neuro, Inc.
Brand item of Alzamend Neuro, Inc.

It is critical for investors to assess the issuer's bankruptcy risk by analyzing its liquidity. Developing innovative dementia drugs requires colossal research expenditures. The current cash position, amounting to 0.01, measures the volume of available reserves to sustain operations and listing. This indicator demonstrates the balance between financial protection and capital efficiency. A sufficient cash reserve confirms the resilience of the Alzamend Neuro, Inc. (ALZN) business model.

Competitors of Alzamend Neuro, Inc.

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Volume AMLX (amylyx.com)|Company Liquid Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Company Cash Volume|Company Cash Reserve Anavex|CBLL (CeriBell Inc) - Company Cash on Hand|Company Cash and Cash Equivalents PRTA|Company Cash Funds Alector Inc.|Company Cash Reserve Annexon, Inc. ANNX|Company Cash Funds Omeros Corp (OMER)|NGNE (Neurogene Inc) - Company Cash Balance|Company Cash Funds AC Immune Inc ACIU|Company Cash Position Voyager Corp|Neumora Corp - Company Cash Volume|scilexholding.com (SCLX) - Company Cash on Hand|Tevogen Bio Holdings, Inc. (TVGN) - Company Cash Funds|Alpha Cognition Corp (ACOG) - Company Cash Volume|Company Cash on Hand CGTX|Company Cash and Cash Equivalents IKT (Inhibikase)|Company Cash Volume SAVA|Assertio - Company Cash and Cash Equivalents|Company Cash Volume COYA (Coya Therapeutics)|Company Cash Volume Vistagen Therapeutics VTGN|OVID: Company Cash on Hand|ABOS - Company Cash Volume|CRVO: Company Cash Volume|Company Cash Reserve Alterity Therapeutics Ltd. (ATHE)|Company Cash Funds Clene Inc.|pepgen.com (PEPG) - Company Liquid Assets|Company Cash on Hand JUNS (jupiterneurosciences.com)|Company Cash Funds RLMD (Relmada Corp)|Annovis Bio, Inc. - Company Cash on Hand|Company Cash Position Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Company Cash Volume|KLTO - Company Cash Volume|NRSN (NeuroSense Therapeutics Ltd.) - Company Cash on Hand|RVPH - Company Liquid Assets|Company Cash Funds MetaVia|Company Cash and Cash Equivalents NRXS (neuraxis.com)|Company Cash Funds Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Company Cash Balance|Company Cash Volume NEUP (Neuphoria Therapeutics)|Company Cash Balance NERV|ATHA - Company Cash Funds|Company Total Cash Volume ADXN|Cyclerion Therapeutics (CYCN) - Company Cash Funds|Company Cash and Cash Equivalents PTIX|KTTA (pasitheaclinics.com) - Company Cash Volume|CRGT (cortigent.com) - Company Total Cash Amount|Company Cash Volume ATXI|Company Cash Funds BCLI (Brainstorm Cell)|Company Cash Volume CARA (Cara Therapeutics Inc)|Company Cash Balance CHRO|Eliem Therapeutics Inc. - Company Cash Volume|ITCI - Company Cash Volume|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE